Australia - English - Department of Health (Therapeutic Goods Administration)

aa-med pty ltd - 45617 - automatic-inflation electronic sphygmomanometer, portable, arm/wrist - the blood pressure monitor is intended to measure the systolic, diastolic and pulse rate of an individual by using non-invasive oscillometric method in which an inflatable cuff is wrapped around the upper arm.

Australia - English - Department of Health (Therapeutic Goods Administration)

aa-med pty ltd - 17888 - thermometer, infrared, skin - the tm 750 infrared thermometer is intended for the intermittent measurement and monitoring of human body temperature by carrying out measurement in the ear or on the forehead.

Australia - English - Department of Health (Therapeutic Goods Administration)

ewingsdale physiotherapy - 17888 - thermometer, infrared, skin - handheld battery powered device that is intended to be used for the monitoring of body temperature of people of all ages. it measures the infrared energy emitted from the skin surface of the forehead .

Australia - English - Department of Health (Therapeutic Goods Administration)

vicki partridge pty ltd - 45617 - automatic-inflation electronic sphygmomanometer, portable, arm/wrist - a battery powered automatic non invasive blood pressure monitor intended to measure the systolic pressure, diastolic pressure and pulse rate measurement cycles via an inflation cuff applied to either the upper arm/or wrist. this device is intended for use for and by an adult for at home monitoring.

Australia - English - Department of Health (Therapeutic Goods Administration)

vicki partridge pty ltd - 63711 - infrared patient thermometer, ear/skin - the infrared thermometer is intended for the intermittent measurement and monitoring of human body temperature by carrying out measurement in the ear or on the forehead.

European Union - English - EMA (European Medicines Agency)

csl behring gmbh - alpha1-proteinase inhibitor (human) - genetic diseases, inborn, lung diseases - antihemorrhagics, - respreeza is indicated for maintenance treatment, to slow the progression of emphysema in adults with documented severe alpha1-proteinase inhibitor deficiency (e.g. genotypes pizz, piz(null), pi(null,null), pisz). patients are to be under optimal pharmacologic and non-pharmacologic treatment and show evidence of progressive lung disease (e.g. lower forced expiratory volume per second (fev1) predicted, impaired walking capacity or increased number of exacerbations) as evaluated by a healthcare professional experienced in the treatment of alpha1-proteinase inhibitor deficiency.,

Australia - English - Department of Health (Therapeutic Goods Administration)

michael stone -

European Union - English - EMA (European Medicines Agency)

bayer ag  - octocog alfa - hemophilia a - antihemorrhagics - treatment and prophylaxis of bleeding in patients with haemophilia a (congenital factor-viii deficiency).this preparation does not contain von willebrand factor and is therefore not indicated in von willebrand's disease.

European Union - English - EMA (European Medicines Agency)

bayer ag - octocog alfa - hemophilia a - antihemorrhagics - treatment and prophylaxis of bleeding in patients with haemophilia a (congenital factor viii deficiency).iblias can be used for all age groups.

European Union - English - EMA (European Medicines Agency)

csl behring gmbh - alpha1-proteinase inhibitor (human) - genetic diseases, inborn, lung diseases - antihemorrhagics, - respreeza is indicated for maintenance treatment, to slow the progression of emphysema in adults with documented severe alpha1-proteinase inhibitor deficiency (e.g. genotypes pizz, piz(null), pi(null,null), pisz). patients are to be under optimal pharmacologic and non-pharmacologic treatment and show evidence of progressive lung disease (e.g. lower forced expiratory volume per second (fev1) predicted, impaired walking capacity or increased number of exacerbations) as evaluated by a healthcare professional experienced in the treatment of alpha1-proteinase inhibitor deficiency.,